Untitled

HealthTrust presents…Virtual HTU: “Current Clinical Controversies & Debates in Infectious Diseases”

Download a copy of this content.

The intersection of infectious diseases and antimicrobial stewardship can be a controversial space. Three common areas of debate include fidaxomicin versus vancomycin for treatment of Clostridioides difficile, oral antibiotics for severe infections, and the most optimal metrics to measure success in antimicrobial stewardship. In this session, presenters will highlight these three current controversies facing antimicrobial stewardship programs and provide real-world application of literature to practice. First, despite new C. difficile guidelines, questions remain on whether fidaxomicin or vancomycin should be first-line. Second, IV antibiotics have been first-line for serious infections, but emerging literature on oral therapy is shifting that paradigm. Lastly, while antimicrobial stewardship has been in existence for decades, the most optimal metric to measure success remains elusive. Novel metrics will be explored and contrasted with traditional metrics.

Learning Objectives | At the end of this session, participants should be able to:

• Recognize novel and non-traditional metrics to measure the success of antimicrobial stewardship programs
• Identify infections conventionally treated with intravenous therapy that may be candidates for oral beta-lactam
  therapy
• Recall the role of fidaxomicin and vancomycin in treatment of C difficile based on updated treatment
  guidelines, literature and practical considerations

Presenters:

Jill Cowper, PharmD, BCIDP  |  Division Infectious Diseases (ID) Pharmacist  |  Healthtrust Supply Chain

Kelli Kronsberg, PharmD, BCPS  |  Infectious Diseases Pharmacist & Program Coordinator for the PGY-2 Infectious Diseases Pharmacy Residency Program  |  MountainView Hospital

Target Audience: Pharmacists, Nurses & Supply Chain Professionals

Continuing Education Information:

• Approved for Nursing, Pharmacy & Supply Chain credit
  • Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour for nurses who attend the webinar and complete the online evaluation. This webinar has been approved by AHRMM for 1.0 contact hour of continuing education.
  • Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Number for this activity is 0863-9999-22-058-L01-P. The activity is approved for 1 hour of continuing education credit to Pharmacists who attend the webinar and complete the online evaluation.
• Members who attended the live HTU event and applied for CE credit are not eligible to receive credit for the same program in a virtual format.
• If you plan to obtain credit for a live session, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.